期刊文献+

PAQR4在肝细胞癌中的表达及其对HepG2细胞生物学特性的影响

Expression of PAQR4 in hepatocellular carcinoma and its effect on the biological characteristics of HepG2 cells
下载PDF
导出
摘要 目的探究PAQR4在肝细胞癌(HCC)中的表达、预后及其对HepG2细胞的增殖、侵袭、迁移和凋亡的影响。方法利用TCGA数据库中HCC的数据分析PAQR4 mRNA在HCC组织中的表达及对患者的预后意义。构建pcDNA3.1-PAQR4实验组与pcDNA3.1-vector对照组的HepG2细胞株。采用CCK-8法检测过表达PAQR4对HepG2细胞增殖的影响。通过细胞划痕实验和Transwell侵袭实验分别检测过表达PAQR4对HepG2细胞迁移和侵袭能力的影响。利用PI和Annexin V双染实验观察过表达PAQR4对HepG2细胞凋亡的影响。结果TCGA数据库数据分析结果显示PAQR4 mRNA在HCC组织中的表达高于癌旁组织(P<0.05),且PAQR4 mRNA高表达组HCC患者的总体生存率低于低表达组(P=0.012)。单因素回归分析显示PAQR4 mRNA表达水平(HR:1.104,95%CI:1.051~1.160,P<0.001)、T分期(HR:1.816,95%CI:1.442~2.287,P<0.001)、M分期(HR:3.924,95%CI:1.230~12.519,P=0.021)、病理分期(HR:1.879,95%CI:1.466~2.408,P<0.001)对HCC患者的预后存在显著影响。多因素回归分析显示PAQR4 mRNA表达水平(HR:1.396,95%CI:1.081~1.804,P=0.011)是HCC患者预后的独立危险因素。CCK-8实验、划痕实验和Transwell侵袭实验结果表明,与对照组相比,实验组中HepG2细胞的增殖、迁移、侵袭能力均明显得到促进(P<0.05)。细胞凋亡实验结果显示过表达PAQR4可以抑制HepG2细胞凋亡(P<0.05)。结论PAQR4在HCC组织中高表达且与预后相关,过表达PAQR4促进HepG2细胞的增殖、侵袭、迁移并抑制HepG2细胞的凋亡。PAQR4有可能成为HCC诊断和预后的新标志物。 Objective To investigate the expression and prognosis of(progestin and adipoQ receptor family member 4,PAQR4)in hepatocellular carcinoma(HCC)and its effect on the proliferation,invasion,migration and apoptosis of HepG2 cells.Methods The HCC data in the cancer genome atlas(TCGA)database was used to analyze the expression of PAQR4 mRNA in the tissues of HCC and its prognostic significance.HepG2 cell lines of pcDNA3.1-PAQR4 experimental group and pcDNA3.1-vector control group were established.CCK-8 assay was used to detect the effect of overexpression PAQR4 on the proliferation of HepG2 cells.The scratch assay and Transwell assay were used to detect the effects of PAQR4 overexpression on the migration and invasion of HepG2 cells.PI and Annexin V double staining experiment was used to observe the effect of PAQR4 overexpression on HepG2 cell apoptosis.Results TCGA database data analysis results showed that the expression of PAQR4 mRNA in HCC tissues was higher than that in adjacent tissues(P<0.05),and the overall survival rate of HCC patients with PAQR4 mRNA high expression group was lower than that of low expression group(P=0.012).Univariate regression analysis showed that PAQR4 mRNA expression level(HR:1.104,95%CI:1.051-1.160,P<0.001),T stage(HR:1.816,95%CI:1.442-2.287,P<0.001),M stage(HR:3.924,95%CI:1.230-12.519,P=0.021),pathological staging(HR:1.879,95%CI:1.466-2.408,P<0.001)had a significant impact on the prognosis of HCC patients.Multivariate regression analysis showed that PAQR4 mRNA expression level(HR:1.396,95%CI:1.081-1.804,P=0.011)was an independent risk factor of the prognosis of HCC patients.The results of CCK-8 assay,scratch assay and Transwell assay showed that the proliferation,migration,invasion and invasion ability of HepG2 cells in the experimental group were significantly improved compared with the control group(P<0.05).Overexpression PAQR4 could inhibit HepG2 cell apoptosis(P<0.05).Conclusion PAQR4 is significantly up-regulated in HCC tissue and is related to the prognosis of the patients.Overexpression PAQR4 promotes the proliferation,invasion and migration of HepG2 cells,and inhibits HepG2 cells apoptosis.PAQR4 maybe a new marker for the diagnosis and prognosis of HCC.
作者 董庆泰 林振宇 李中虎 张智勇 马丹丹 蔡逊 Dong Qingtai;Lin Zhenyu;Li Zhonghu;Zhang Zhiyong;Ma Dandan;Cai Xun(The First School of Clinical Medicine, Southern Medical University, Guangzhou 510515;Dept of General Surgery, The Central Theater Hospital of The Chinese People′s Liberation Army, Wuhan 430070)
出处 《安徽医科大学学报》 CAS 北大核心 2022年第1期26-31,共6页 Acta Universitatis Medicinalis Anhui
基金 国家自然科学基金(编号:81902501) 湖北省卫生健康委员会联合基金项目(编号:WJ2019H104)。
关键词 PAQR4 肝细胞癌 增殖 侵袭 迁移 凋亡 progestin and adipoQ receptor family member 4 hepatocellular carcinoma proliferation invasion migration apoptosis
  • 相关文献

参考文献3

二级参考文献23

  • 1Caterina Pozzan,Romilda Cardin,Marika Piciocchi,Nora Cazzagon,Gemma Maddalo,Veronica Vanin,Anna Giacomin,Patrizia Pontisso,Umberto Cillo,Fabio Farinati.Diagnostic and prognostic role of SCCA ‐ IgM serum levels in hepatocellular carcinoma ( HCC )[J]. J Gastroenterol Hepatol . 2014 (8)
  • 2Rebecca Siegel,Deepa Naishadham,Ahmedin Jemal.Cancer statistics, 2013[J]. CA: A Cancer Journal for Clinicians . 2013 (1)
  • 3Zhong-Bo Han,Hong-Yuan Chen,Jun-Wei Fan,Jun-Yi Wu,Hua-Mei Tang,Zhi-Hai Peng.Up-regulation of microRNA-155 promotes cancer cell invasion and predicts poor survival of hepatocellular carcinoma following liver transplantation[J].Journal of Cancer Research and Clinical Oncology.2012(1)
  • 4Sean F. Altekruse,Katherine A. McGlynn,Marsha E. Reichm.Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005. Japanese Journal of Clinical Oncology . 2009
  • 5Gupta Samir,Bent Stephen,Kohlwes Jeffrey.Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis. Annals of Internal Medicine . 2003
  • 6Patrick Reichl,Meng Fang,Patrick Starlinger,Katharina Staufer,Rudolf Nenutil,Petr Muller,Kristina Greplova,Dalibor Valik,Steven Dooley,Christine Brostjan,Thomas Gruenberger,Jiayun Shen,Kwan Man,Michael Trauner,Jun Yu,Chun Fang Gao,Wolfgang Mikulits.Multicenter analysis of soluble A xl reveals diagnostic value for very early stage hepatocellular carcinoma[J]. Int. J. Cancer . 2015 (2)
  • 7Athina Chounta,Christofer Ellinas,Vassiliki Tzanetakou,Fani Pliarhopoulou,Virginia Mplani,Angelos Oikonomou,Kostantinos Leventogiannis,Evangelos J. Giamarellos‐Bourboulis.Serum soluble urokinase plasminogen activator receptor as a screening test for the early diagnosis of hepatocellular carcinoma[J]. Liver Int . 2015 (2)
  • 8Karim Y. A. Shaheen,Abeer I. Abdel-Mageed,Eslam Safwat,Ashraf M. AlBreedy,Shigeru Marubashi.The Value of Serum Midkine Level in Diagnosis of Hepatocellular Carcinoma[J]. International Journal of Hepatology . 2015
  • 9Nicolas Poté,Fran?ois Cauchy,Miguel Albuquerque,Hélène Voitot,Jacques Belghiti,Laurent Castera,Hervé Puy,Pierre Bedossa,Valérie Paradis.Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion[J]. Journal of Hepatology . 2014
  • 10Xiaobo Jia,Jiao Liu,Yingtang Gao,Yong Huang,Zhi Du.Diagnosis Accuracy of Serum Glypican-3 in Patients with Hepatocellular Carcinoma: A Systematic Review with Meta-analysis[J]. Archives of Medical Research . 2014 (7)

共引文献85

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部